The EM medical literature monitoring service enters into full effect

On 1 September 2015, the European Medicines Agency (“EMA”) announced that its medical literature monitoring service, which is intended to identify suspected adverse reactions with medicinal products authorised in the European Union (“EU”) had entered into full effect.

To read more, click here.

Download PDF Share Back To Listing
Loading data